CN Patent

CN121729420A — 寡核苷酸合成方法

Assigned to Arrowhead Pharmaceuticals Inc · Expires 2026-03-24 · 0y expired

What this patent protects

本文中公开了用于制备寡核苷酸的工艺或方法，包括以大的单一批次规模并具有高纯度和产率，而没有加帽步骤。

USPTO Abstract

本文中公开了用于制备寡核苷酸的工艺或方法，包括以大的单一批次规模并具有高纯度和产率，而没有加帽步骤。

Drugs covered by this patent

plozasiran-sodium (PLOZASIRAN SODIUM)

Patent Metadata

Patent number: CN121729420A
Jurisdiction: CN
Classification: —
Expires: 2026-03-24
Drug substance claim: No
Drug product claim: No
Assignee: Arrowhead Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.